Dirk Lange has been appointed Chief Executive Officer of Pyramid Labs, Inc., a medicinal product contract development and manufacturing company with experience in proteins, oligos, and peptides. As chairman of Pyramid, Medhat Gorgy, who established the company in 1988 and has guided its expansion and development over the course of its 36-year existence, will continue to assist the enterprise.
Dirk Lange expressed his excitement at taking the helm of Pyramid at this crucial juncture in the company’s growth trajectory, as it is double its commercial fill-finish capacity. Clients need to safeguard their prescription product supply chain now more than ever, and we are building on a 36-year history of excellence, dependability, and innovation. Due to Pyramid’s unwavering attention to performance and integrity, exceptional service levels were produced, enabling numerous clients to fulfill their goals and introduce items into the market and clinic.
In the CDMO industry, Lange brings a plethora of knowledge and experience to the table when it comes to creating and managing international teams and giving their clientele the best services available. Prior to leading MilliporeSigma’s Life Science Services division, Lange served as CEO of KBI Biopharma and Selexis. He joins Pyramid at a time when it is experiencing rapid expansion, having doubled its capacity for commercial fill-finish.
According to Lange, there is a growing need for our DP development and manufacturing services in the fields of biologics, small molecules, and particularly novel modalities like oligo nucleotides, where Pyramid provides years of knowledge and unique capabilities.
Pyramid Labs was established by Mr. Gorgy in 1988 and has since grown to become a market leader in formulation development, lyophilization, aseptic fill-finish biologics, and analytical services for the biotech and pharmaceutical sectors. Over the past 36 years, he has led Pyramid in building a best-in-class reputation for quality, technical know-how, and customer service. As Chairman, he will continue to support the company.
As we continue in our transformative growth phase, they are thrilled to have Dirk join the Pyramid team, said Medhat Gorgy. Pyramid is excited to support him in his new role as Chairman and will gain from his extensive experience in the pharmaceutical industry and depth of knowledge in this field.
Managing Director Steve Weaver and Audax Private Equity Partner Keith Palumbo expressed their gratitude for Medhat’s leadership throughout Pyramid’s lengthy history. He guided the Company through a period of extraordinary growth, built an exceptional quality- and service-oriented organization, and positioned Pyramid for sustained future success, they said. In this next phase of Pyramid’s development, Dirk will contribute his proven knowledge and strategic leadership to assist the company maintain its momentum and grow faster.
Pyramid has made significant investments to increase its capacity to better serve its clients since Audax Private Equity’s investment in 2023. One such investment was the construction of the facility to double the capacity for syringe and vial filling.
Based in California, Pyramid Labs, Inc. is a CDMO that specializes in aseptic fill-finish manufacturing, analytical and stability testing, and formulation development for clinical and commercial stage products. Pyramid was established in 1988 and has its headquarters located in Orange County, California. The company has three manufacturing facilities that enable it to provide a comprehensive range of services to its pharmaceutical and biotech clients. These services include preclinical development, as well as scaled-up aseptic fill-finish commercial manufacturing, storage, and distribution.
